Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

NCT01368263 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Due to funding source and lack of accrual

Conditions

Estrogen Receptor-positive Breast Cancer
HER2-negative Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions

DRUG: goserelin acetate
DRUG: letrozole
DRUG: anastrozole
DRUG: chemotherapy
PROCEDURE: Surgery

Sponsor

Washington University School of Medicine

Collaborators

[object Object]